The Enhanced Liver Fibrosis (ELF) Test is a noninvasive blood test that measures three direct markers of fibrosis.
Enhanced Liver Fibrosis (ELF) Test
Assess the risk of NAFLD/NASH progression and liver-related events with a simple blood test.
Real-world Evidence and Value
Assessing fibrosis risk with a more accessible blood test can help improve clinical and financial outcomes.
ELF Test indicated as top-performing biomarker in NIMBLE study
Helping to Reshape NASH Clinical Trials
Addressing the rising prevalence of Non-alcoholic Fatty Liver Disease
Learn more about:
Hear from the Experts
Hear from key opinion leaders about the rising prevalence of NAFLD/NASH and the need for non-invasive tests.
Medcape Video: Evolution of Diagnosis and Monitoring for Liver Fibrosis
Four experts discuss how timely identification of patients at risk of progression using noninvasive diagnostic tests is crucial.
Hear from a few Siemens Healthineers colleagues working to help turn the tide against the liver's silent killer – NASH
The products/features (mentioned herein) are not commercially available in all countries. Their future availability cannot be guaranteed.